Literature DB >> 8970629

Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation.

M Yazaki1, S Ikeda, Y Takei, N Yanagisawa, H Matsunami, Y Hashikura, S Kawasaki, M Makuuchi, K Kobayashi, T Saheki.   

Abstract

Type II citrullinemia is an adult-onset hepatocerebral disease caused by a deficiency of argininosuccinate synthetase in liver. A 25-year-old Japanese man suddenly developed encephalopathy, showing disorientation and flapping tremor. Plasma concentrations of ammonia and citrulline were extremely high, and hepatic argininosuccinate synthetase activity was deficient. The patient's condition deteriorated rapidly in spite of intensive medications. Therefore, we performed a partial liver transplantation using a graft obtained from his healthy 61-year-old father. After surgery, his neurological symptoms soon disappeared and plasma levels of ammonia and citrulline were normalized within 3 months after operation. Type II citrullinemia is one fulminant form of various liver-based metabolic diseases, and immediate liver transplantation is necessary to rescue patients with this disease. As liver transplantation from cadaveric donor is still not possible in Japan, it seems justifiable to use living related partial liver transplantation for our patient.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970629     DOI: 10.1097/00007890-199612150-00027

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Hepatocellular carcinoma associated with adult-type citrullinemia.

Authors:  T Ito; K Shiraki; K Sekoguchi; T Yamanaka; K Sugimoto; K Takase; Y Tameda; T Nakano
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia.

Authors:  T Yasuda; N Yamaguchi; K Kobayashi; I Nishi; H Horinouchi; M A Jalil; M X Li; M Ushikai; M Iijima; I Kondo; T Saheki
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

Review 3.  Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency.

Authors:  Takeyori Saheki; Keiko Kobayashi; Mikio Iijima; Ikumi Nishi; Tomotsugu Yasuda; Naoki Yamaguchi; Hong Zhi Gao; Md Abdul Jalil; Laila Begum; Meng Xian Li
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

4.  Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation.

Authors:  S Ikeda; M Yazaki; Y Takei; T Ikegami; Y Hashikura; S Kawasaki; M Iwai; K Kobayashi; T Saheki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

5.  Liver transplantation for the treatment of urea cycle disorders.

Authors:  P F Whitington; E M Alonso; J T Boyle; J P Molleston; P Rosenthal; J C Emond; J M Millis
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

6.  Liver transplantation in an adult with citrullinaemia type 2.

Authors:  Hui-Hui Tan; Wan-Cheng Chow; Kiat-Hon Lim; Wei-Keat Wan; Alexander Y F Chung; Peng-Chung Cheow; Chee-Kiat Tan
Journal:  J Transplant       Date:  2011-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.